COMMUNIQUÉS West-GlobeNewswire

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma
10/09/2025
Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical activity and durability Highly encouraging initial clinical results for [...]
LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
10/09/2025
BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has made an [...]
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/09/2025
DUBLIN, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
10/09/2025
ROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Andy Brown has joined [...]
Keystone Place at Newbury Brook Senior Living Community Expands with 39 New Apartments, Launches Innovative Transitional Memory Care.
10/09/2025
TORRINGTON, CT , Sept. 10, 2025 (GLOBE NEWSWIRE) -- In response to the growing demands for senior living apartments, Keystone Place at Newbury Brook in Torrington Connecticut has completed a brand-new addition of 39 [...]
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/09/2025
SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]
Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate
10/09/2025
- Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in the company’s previous Phase 2b challenge study - SOUTH SAN FRANCISCO, Calif., [...]
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
10/09/2025
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and Discovery FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster [...]
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
10/09/2025
WINNIPEG, Manitoba, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) today announces that it has enrolled 28 participants in its revyve ® Antimicrobial Wound Gel and Spray U.S [...]
Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers
10/09/2025
The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a [...]
Design Therapeutics Appoints Justin Gover to Board of Directors
10/09/2025
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10/09/2025
PALO ALTO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that the [...]
Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier
10/09/2025
Dermatology2Go se focalise sur les soins de la peau en ligne, sans temps d’attente et avec des informations fiables BERGEN OP ZOOM, Pays-Bas, 10 sept. 2025 (GLOBE NEWSWIRE) -- Une nouvelle plateforme néerlandaise a été [...]
Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
10/09/2025
LOS ANGELES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology
10/09/2025
Collaboration aims to create the lab of the future, enabling safer, faster, and more precise interventions Key Benefits of Partnership Integration of VR and imaging: Combines Realize Medical’s VR platform with Canon’s [...]
Johns Hopkins Health Plans Opens 2026 Grant Application Period
10/09/2025
Baltimore-Washington Region Nonprofits Invited to Apply for Grants Up to $20,000 HANOVER, Md., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has launched the grant application period for its 2026 [...]
Partnership between Corewell Health and Nudj Health drives progress in chronic condition management
10/09/2025
The model is making lasting improvements to thousands of patients who have a broad spectrum of chronic conditions AUSTIN, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Corewell Health ™ patients who used virtual lifestyle [...]
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform
10/09/2025
RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™ , one of the largest digital health platforms for men, to make KYZATREX ® , an FDA- [...]
Tecan announces change of leadership in the Partnering Business division
10/09/2025
Männedorf, Switzerland, September 10, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering [...]

Pages